Max Super Speciality Hospital, Dwarka – India 
About Dr. Hari Goyal
Dr. Hari Goyal is a senior medical oncologist with over two decades of experience in cancer care, specializing in chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. Trained at premier Indian institutions, he has played a key role in advancing biosimilar research and participating in FDA-audited global clinical trials. Dr. Goyal is known for his personalized, patient-centric treatment plans and compassionate care approach. He has treated patients from over 25 countries and is recognized for his transparency, consistency, and innovative outlook in oncology. His work combines scientific precision with deep empathy, making him a trusted name in cancer treatment.
OPD Schedule Of Dr. Hari Goyal
Consultation Fees Rs. 1400 /-
Artemis Hospital, Gurgaon
MON
11:00 AM - 03:00 PM
TUE
11:00 AM - 03:00 PM
WED
11:00 AM - 03:00 PM
THU
11:00 AM - 03:00 PM
FRI
11:00 AM - 03:00 PM
SAT
11:00 AM - 03:00 PM
- MBBS – Sardar Patel Medical College, Bikaner, India
- MD (Internal Medicine) – SMS Medical College, Jaipur, India
- DM (Medical Oncology) – AIIMS, New Delhi, India
- Professional Diploma in Clinical Research (PDCR)
- ICH-GCP Certification – TransCelerate, 2022
- Cancer Types Treated: Breast, Lung, Liver, Gastrointestinal, Genitourinary cancers
- Hematologic Malignancies: Acute Lymphocytic Leukemia, Hairy Cell Leukemia
- Sub-specialties: Chemotherapy, Immunotherapy, Hormonal Therapy, Targeted Therapy
- Advanced Approaches: Adjuvant and Neoadjuvant Cancer Chemotherapy, Metastatic Cancer Management
- Principal Director & Unit Head – Medical Oncology, Max Super Specialty Hospital, Dwarka, New Delhi (Current)
- Chief – Medical Oncology, Artemis Hospital, Gurugram
- Junior Registrar, Tata Memorial Centre, Mumbai
- Consultant, AIIMS, New Delhi
- Consultant, Rajiv Gandhi Cancer Institute, New Delhi
- Consultant, BLK Super Specialty Hospital, New Delhi
- Consultant, Action Cancer Hospital, New Delhi
- Consultant, Batra Hospital, New Delhi
- Triveni Ratna Award – Presented by MP Shri Mahabal Mishra
- Unnat Bharat Seva Award – Conferred by the Union Minister of Agriculture at the Parliament Annexe
- Publications: Authored over 30 research papers in national and international journals
- Clinical Trials: Active participation in FDA-audited clinical trials for metastatic breast cancer
- Focus Areas:
- Biosimilar efficacy in HER2-positive breast cancer
- Development of immunotherapy agents, including Durvalumab, Tremelimumab, and Atezolizumab
Consultation Fee: To know more about consultation fees or to book your appointment, feel free to connect with the Cancer Rounds team — we’re here to guide you every step of the way!
Treatment Costs:
Treatment Cost Table
| Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
| Chemotherapy (per cycle) | ₹20,000 – ₹1,50,000 | $240 – $1,800 |
| Immunotherapy (per cycle) | ₹1,00,000 – ₹4,00,000 | $1,200 – $4,800 |
| Targeted Therapy (per month) | ₹1,80,000 – ₹3,50,000 | $2,160 – $4,200 |
| Hormonal Therapy (per month) | ₹50,000 – ₹65,000 | $600 – $780 |
| Biosimilar Trastuzumab (per cycle) | ₹19,995 – ₹63,000 | $240 – $756 |
We offer comprehensive support for international patients:
- Medical visa assistance
- Appointment scheduling
- Personalized treatment planning and cost estimates
- Language interpretation services
- Post-treatment virtual consultations
Patients consistently commend Dr. Hari Goyal for his transparent communication, dedication, and holistic approach to cancer care. Here are some testimonials
“Dr. Hari Goyal’s communication, truthful discussions about outcomes, and energetic attitude are the key to his present success.” “Consistency, punctuality, and empathy are some of his qualities which his patients and colleagues admire.”
Patient-Centered Care:
Dr. Hari Goyal, a medical oncologist, is a strong advocate of patient-centered care. He believes in tailoring cancer therapies to each patient’s unique needs, integrating cutting-edge treatments with empathetic care. His focus is on empowering patients through informed choices, ensuring that treatment aligns with their medical and personal needs.
Innovation & Compassion:
By leading FDA-audited clinical trials and championing biosimilar research, Dr. Hari Goyal continually bridges innovation and compassionate oncology practice. His innovative approach to cancer treatment inspires hope and confidence in his patients and colleagues alike.
Frequently Asked Questions
A: International patients can arrange virtual consultations and pre-treatment discussions via authorized hospital coordinators or medical tourism facilitators.
A: Dr. Hari Goyal treats a wide range of cancers, including breast, lung, gastrointestinal, liver, and hematologic malignancies.
A: Yes, chemotherapy regimens are carefully customized based on the patient’s cancer type, stage, and overall health.
Indraprastha Apollo Hospital, New Delhi - India 
Stem Cell Treatment for Breast Cancer
